Medisoft, Inc. – Trademark Portfolio
Entity Type: 11
Medisoft, Inc. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 8 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include HIMSHOP, FROM MARS, FROM VENUS, and PRESCRIPTION CARE. The owner is based in Englewood, CO.
900 East Oxford Lane
Englewood, CO 80110
Showing of trademarks Trademarks
Trademark Classifications
Medisoft, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Medisoft, Inc. have?
Medisoft, Inc. has 12 U.S. trademarks filed with the USPTO. Of these, 6 registered, 4 abandoned, 2 cancelled.
What trademark classes does Medisoft, Inc. file in?
Medisoft, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 35 covers advertising; business management; business administration; office functions.
What are Medisoft, Inc.'s most well-known trademarks?
Medisoft, Inc.'s registered trademark portfolio includes well-known marks such as HIMSHOP, FROM MARS, FROM VENUS, and PRESCRIPTION CARE. These are among 6 currently registered trademarks in the portfolio.
What is Medisoft, Inc.'s trademark registration success rate?
Medisoft, Inc. has a 50% trademark registration rate, with 6 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.